Niagara University Receives New York State Biodefense Award to Develop Novel Anti-Viral Therapy
July 27, 2024
July 27, 2024
NIAGARA FALLS, New York, July 27 (TNSres) -- Niagara University issued the following news:
By Lisa McMahon
Niagara University has been selected to receive a grant from the New York State Biodefense Commercialization Fund. The award of nearly $261,500 will be used to formulate a general anti-viral therapeutic using CholestosomeTM technology, a molecule delivery system developed at Niagara by Dr. Mary McCourt, professor of chemistry. It was one of just three academic inst . . .
By Lisa McMahon
Niagara University has been selected to receive a grant from the New York State Biodefense Commercialization Fund. The award of nearly $261,500 will be used to formulate a general anti-viral therapeutic using CholestosomeTM technology, a molecule delivery system developed at Niagara by Dr. Mary McCourt, professor of chemistry. It was one of just three academic inst . . .